Pink Sheet

Timing is Everything: Biotech Pioneers Push Follow-On Biologics Proposal

01 Apr 2007

• By Ramsey Baghdadi

Once unthinkable, the pioneer biotech firms are jumping in with their own proposals for an abbreviated follow-on biologics regulatory pathway. They recognize that this may be the best time for many years to get a system that builds in rigorous tests for follow-ons.

By Ramsey Baghdadi

Senator Ted Kennedy is close to brokering a deal for additional risk management and postmarket surveillance authority for the Food...